STE
STERIS
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 3
Sell signal 2
consensus rating "Buy"
Bearish Engulfing
ample liquidity
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
--DAY`S RANGE--
--52 WK RANGE--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
About STE
Steris Plc
A leading global provider of products and services that support patient care with an emphasis on infection prevention
Healthcare Equipment and Supplies
10/09/2014
03/28/2019
New York Stock Exchange
18000
03-31
Common stock
70 Sir John Rogerson’s Quay, Dublin 2 , Ireland D02 R296
--
STERIS plc is a private limited liability company incorporated under the laws of England and Wales, established on October 9, 2014, to provide a range of professional outsourcing services to healthcare providers and other clients related to health management.
Company Financials
EPS
STE has released its 2025 Q3 earnings. EPS was reported at 2.32, versus the expected 2.32, meeting expectations. The chart below visualizes how STE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
STE has released its 2025 Q3 earnings report, with revenue of 1.37B, reflecting a YoY change of 5.61%, and net profit of 173.29M, showing a YoY change of 22.95%. The Sankey diagram below clearly presents STE’s revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
